Evaluation of combined BCL-2/MCL-1 inhibition as a therapeutic approach for synovial sarcoma.

Carter Kent Fairchild , Konstantinos Floros , Sheeba Jacob , Colin Coon
Journal of Clinical Oncology 38 ( 15_suppl) e23561 -e23561

1
2020
NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Matthew Ingham , Jacob B Allred , Katherine Gano , Suzanne George
Journal of Clinical Oncology 38 ( 15_suppl) TPS11570 -TPS11570

2020
Tumor mutation burden and PD-L1 expression in SDH/FH mutated solid tumors.

Leylah Drusbosky , Christopher Szeto , Sandeep K Reddy , Maninderjit Ghotra
Journal of Clinical Oncology 37 1524 -1524

2019
Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities.

Jacob J Adashek , Christopher Szeto , J Zack Sanborn , Sandeep K Reddy
Journal of Clinical Oncology 38 3576 -3576

2020
Risk stratification of gastrointestinal stromal tumors by CtBP2 and CD44 analysis.

Priya Gopie , Oana C. Rosca , Ayesha Chawla , Lin Mei
Journal of Clinical Oncology 36 48 -48

1
2018
Prognostic factors of malignant paraganglioma and pheochromocytoma: A SEER database review.

Lin Mei , Francesco Celi , Steven Smith , Le Kang
Journal of Clinical Oncology 36

2018
Multi-omic characterization of gastrointestinal stromal tumor (GIST) in a large real-world patient cohort.

Jonathan C Trent , David Gómez-Peregrina , Andrew Elliott , Sosipatros Alexandros Boikos
Journal of Clinical Oncology 41 ( 16_suppl) 11522 -11522

1
2023
Characterizing patterns of mTORC1 activation across sarcoma subtypes using single-sample gene set enrichment analysis (ssGSEA) and a national biomarker database.

Daniel S Lefler , Andrew Elliott , Erik Blomain , Robert G Maki
Journal of Clinical Oncology 42 ( 16_suppl) 11544 -11544

2024
Cancer immunotherapy: Identifying cancer testis antigen peptides to enhance antitumor response.

Syed Mahdee Haque , Abdul-Rahman Salman , Hamdi Abdeen , Elizabeth Krieger
Journal of Clinical Oncology 40 ( 16_suppl) e20022 -e20022

1
2022
NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Matthew Ingham , Jacob B Allred , Katherine Gano , Suzanne George
Journal of Clinical Oncology 39 ( 15_suppl) 11506 -11506

14
2021
Correlative results from NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Sminu Bose , Matthew Ingham , Li Chen , Bose Kochupurakkal
Journal of Clinical Oncology 40 ( 16_suppl) 11509 -11509

6
2022
Phase I study of NEROFE and doxorubicin in KRAS-mutated ST2-positive solid tumors.

Benjamin Adam Weinberg , Hongkun Wang , Joshua E Reuss , Sosipatros Alexandros Boikos
Journal of Clinical Oncology 41 ( 16_suppl) TPS2667 -TPS2667

2023
Racial differences in prognostic role of white blood cell ratios in gastrointestinal stromal tumors.

Nikita Chintapally , Markos Kashiouris , Zhonghua Liu , Enrico Bautista
Journal of Clinical Oncology 41 ( 16_suppl) e23507 -e23507

2023
Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone

K. M. Tsang , M. F. Starost , M. Nesterova , S. A. Boikos
Proceedings of the National Academy of Sciences of the United States of America 107 ( 19) 8683 -8688

34
2010
Recurrent epimutation of SDHC in gastrointestinal stromal tumors.

J. K. Killian , M. Miettinen , R. L. Walker , Y. Wang
Science Translational Medicine 6 ( 268)

172
2014
Prostate cancer cells up-regulate PD-L1 in response to pro-inflammatory cytokines. [abstract].

Charles G. Drake. Sosipatros A. Boikos , Chris Nirschl , Allison
Cancer Research 73 ( (8 supplement)) Abstract nr 1437 -Abstract nr 1437

2013
Medullary thyroid carcinoma, RET mutations and the multiple endocrine neoplasia-2 (MEN 2) syndromes

Stratakis CA. Pack S , Boikos S
ASCO Educational Book 43rd Meeting 2007 668 -672

2007
MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system Xc-/glutathione axis

Anthony C. Faber , Bin Hu , Sosipatros A. Boikos , Jennifer E. Koblinski
Cancer Research 81 ( 7) 1896 -1908

1
2021
Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors.

Maurizio Scaltriti , Maurizio Scaltriti , Anthony C. Faber , Bin Hu
Cell Death and Disease 12 ( 2) 1 -13

2021